Perpetual Ltd Has $175.34 Million Stake in Corteva, Inc. $CTVA

Key Points

• Perpetual Ltd increased its Corteva stake by 78,688.5% in Q4, buying an additional 2,612,459 shares to own 2,615,779 shares worth about $175.34 million, making Corteva ~2.5% of Perpetual’s portfolio and its 8th largest position (≈0.39% of Corteva outstanding).
• Corteva’s recent quarter missed revenue estimates ($3.91B vs. $4.23B) with EPS of $0.22, the company guides FY2026 EPS to 3.45–3.70, and the stock trades at a market cap of $57.4 billion with a consensus analyst target of about $83.19 ("Moderate Buy").
• Institutional ownership is high at 81.54%, several analysts have raised price targets (RBC to $89, Wolfe to $86) while one cut to "hold," and insiders own just 0.14% with insider Brian Titus recently selling 8,311 shares.

Perpetual Ltd lifted its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 78,688.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,615,779 shares of the company's stock after purchasing an additional 2,612,459 shares during the quarter. Corteva comprises about 2.5% of Perpetual Ltd's investment portfolio, making the stock its 8th biggest position. Perpetual Ltd owned about 0.39% of Corteva worth $175,336,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. SteelPeak Wealth LLC bought a new stake in Corteva in the 4th quarter worth approximately $3,891,000. Vista Investment Partners LLC bought a new position in shares of Corteva during the 4th quarter valued at approximately $537,000. Trust Co. of Vermont boosted its position in shares of Corteva by 3.8% during the 4th quarter. Trust Co. of Vermont now owns 95,960 shares of the company's stock valued at $6,432,000 after acquiring an additional 3,550 shares during the last quarter. Affinity Wealth Management LLC increased its position in Corteva by 3.7% in the fourth quarter. Affinity Wealth Management LLC now owns 5,279 shares of the company's stock worth $354,000 after purchasing an additional 189 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its stake in Corteva by 5.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 69,199 shares of the company's stock valued at $4,689,000 after purchasing an additional 3,773 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Price Performance

Corteva stock opened at $85.50 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock has a market cap of $57.40 billion, a price-to-earnings ratio of 54.12, a price-to-earnings-growth ratio of 2.92 and a beta of 0.68. The firm has a 50-day moving average of $77.62 and a two-hundred day moving average of $70.10. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $85.56.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts' consensus estimates of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company's quarterly revenue was down 1.7% compared to the same quarter last year. During the same period last year, the company posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva's payout ratio is 45.57%.

Analysts Set New Price Targets

Several research firms have commented on CTVA. Wall Street Zen lowered shares of Corteva from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. Oppenheimer set a $86.00 target price on shares of Corteva in a research report on Thursday, February 5th. Wolfe Research increased their price target on shares of Corteva from $81.00 to $86.00 and gave the company an "outperform" rating in a report on Thursday, February 5th. Royal Bank Of Canada lifted their price target on Corteva from $80.00 to $89.00 and gave the stock an "outperform" rating in a research report on Thursday, February 5th. Finally, Berenberg Bank boosted their price objective on Corteva from $68.00 to $78.00 and gave the stock a "hold" rating in a research note on Thursday, March 26th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and a consensus target price of $83.19.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the company's stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.14% of the stock is currently owned by company insiders.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.